Profile | GDS5420 / AFFX-r2-Bs-phe-5_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 679.12 | 72 |
GSM1296119 | B_lesional_pre-dose | 284.57 | 58 |
GSM1296076 | C_lesional_pre-dose | 200.05 | 54 |
GSM1296092 | D_lesional_pre-dose | 399.64 | 65 |
GSM1296103 | E_lesional_pre-dose | 723.45 | 74 |
GSM1296078 | F_lesional_pre-dose | 216.6 | 55 |
GSM1296107 | G_lesional_pre-dose | 489.04 | 67 |
GSM1296109 | H_lesional_pre-dose | 727.83 | 74 |
GSM1296080 | I_lesional_pre-dose | 963.37 | 78 |
GSM1296090 | J_lesional_pre-dose | 250.19 | 57 |
GSM1296074 | K_lesional_pre-dose | 181.52 | 53 |
GSM1296111 | L_lesional_pre-dose | 451.41 | 66 |
GSM1296099 | M_lesional_pre-dose | 469.31 | 66 |
GSM1296086 | O_lesional_pre-dose | 310.27 | 61 |
GSM1296117 | P_lesional_pre-dose | 357.06 | 62 |
GSM1296113 | Q_lesional_pre-dose | 498.31 | 67 |
GSM1296096 | R_lesional_pre-dose | 374.52 | 63 |
GSM1296105 | S_lesional_pre-dose | 443.26 | 65 |
GSM1296098 | T_lesional_pre-dose | 1036.7 | 80 |
GSM1296101 | U_lesional_pre-dose | 625.81 | 71 |
GSM1296121 | V_lesional_pre-dose | 376.86 | 63 |
GSM1296088 | W_lesional_pre-dose | 613.32 | 71 |
GSM1296082 | X_lesional_pre-dose | 222.99 | 56 |
GSM1296115 | Y_lesional_pre-dose | 449.81 | 66 |
GSM1296084 | Z_lesional_pre-dose | 580.12 | 70 |
GSM1296072 | B_lesional_day8 | 259.94 | 56 |
GSM1296069 | L_lesional_day8 | 429.48 | 64 |
GSM1296071 | P_lesional_day8 | 497.13 | 67 |
GSM1296070 | Y_lesional_day8 | 445.58 | 65 |
GSM1296073 | V_lesional_day8 | 254.37 | 57 |
GSM1296034 | A_lesional_day15 | 1618.73 | 87 |
GSM1296041 | G_lesional_day15 | 465.33 | 67 |
GSM1296035 | R_lesional_day15 | 416.11 | 64 |
GSM1296038 | U_lesional_day15 | 376.28 | 63 |
GSM1296047 | B_lesional_day15 | 353.72 | 61 |
GSM1296039 | E_lesional_day15 | 260.13 | 57 |
GSM1296042 | H_lesional_day15 | 419.09 | 64 |
GSM1296043 | L_lesional_day15 | 551.86 | 69 |
GSM1296037 | M_lesional_day15 | 573.85 | 70 |
GSM1296046 | P_lesional_day15 | 455.66 | 66 |
GSM1296044 | Q_lesional_day15 | 507.53 | 67 |
GSM1296045 | Y_lesional_day15 | 418.57 | 64 |
GSM1296025 | C_lesional_day15 | 654.77 | 72 |
GSM1296033 | D_lesional_day15 | 408.55 | 64 |
GSM1296027 | I_lesional_day15 | 342.06 | 62 |
GSM1296032 | J_lesional_day15 | 818.39 | 76 |
GSM1296024 | K_lesional_day15 | 422.36 | 65 |
GSM1296031 | W_lesional_day15 | 815.3 | 76 |
GSM1296028 | X_lesional_day15 | 404.3 | 64 |
GSM1296029 | Z_lesional_day15 | 778.24 | 75 |
GSM1296026 | F_lesional_day15 | 195.17 | 53 |
GSM1296030 | O_lesional_day15 | 366.77 | 63 |
GSM1296040 | S_lesional_day15 | 802.65 | 75 |
GSM1296036 | T_lesional_day15 | 893.88 | 77 |
GSM1296048 | V_lesional_day15 | 276.61 | 58 |
GSM1296059 | A_lesional_day43 | 457.59 | 66 |
GSM1296066 | G_lesional_day43 | 466.02 | 66 |
GSM1296060 | R_lesional_day43 | 409.29 | 64 |
GSM1296063 | U_lesional_day43 | 238.32 | 55 |
GSM1296064 | E_lesional_day43 | 294.98 | 59 |
GSM1296067 | H_lesional_day43 | 559.25 | 69 |
GSM1296062 | M_lesional_day43 | 774.09 | 75 |
GSM1296068 | Q_lesional_day43 | 454.09 | 65 |
GSM1296050 | C_lesional_day43 | 326.85 | 61 |
GSM1296057 | D_lesional_day43 | 371.74 | 62 |
GSM1296052 | I_lesional_day43 | 336.46 | 62 |
GSM1296054 | J_lesional_day43 | 859.07 | 76 |
GSM1296049 | K_lesional_day43 | 554.41 | 69 |
GSM1296055 | W_lesional_day43 | 592.68 | 70 |
GSM1296053 | X_lesional_day43 | 674.88 | 72 |
GSM1296058 | Z_lesional_day43 | 379.37 | 63 |
GSM1296051 | F_lesional_day43 | 237.42 | 56 |
GSM1296056 | O_lesional_day43 | 295.22 | 60 |
GSM1296065 | S_lesional_day43 | 325.35 | 60 |
GSM1296061 | T_lesional_day43 | 1303.86 | 83 |
GSM1296095 | A_non-lesional_pre-dose | 453.58 | 66 |
GSM1296120 | B_non-lesional_pre-dose | 411.52 | 64 |
GSM1296077 | C_non-lesional_pre-dose | 287.97 | 59 |
GSM1296093 | D_non-lesional_pre-dose | 1107.21 | 81 |
GSM1296104 | E_non-lesional_pre-dose | 480.63 | 67 |
GSM1296079 | F_non-lesional_pre-dose | 463.84 | 67 |
GSM1296108 | G_non-lesional_pre-dose | 531.98 | 69 |
GSM1296110 | H_non-lesional_pre-dose | 594.74 | 70 |
GSM1296081 | I_non-lesional_pre-dose | 1567.32 | 85 |
GSM1296091 | J_non-lesional_pre-dose | 383.48 | 63 |
GSM1296075 | K_non-lesional_pre-dose | 191.81 | 53 |
GSM1296112 | L_non-lesional_pre-dose | 602.46 | 70 |
GSM1296100 | M_non-lesional_pre-dose | 893.75 | 77 |
GSM1296087 | O_non-lesional_pre-dose | 247.93 | 57 |
GSM1296118 | P_non-lesional_pre-dose | 637.87 | 71 |
GSM1296114 | Q_non-lesional_pre-dose | 645.32 | 72 |
GSM1296097 | R_non-lesional_pre-dose | 376.35 | 63 |
GSM1296106 | S_non-lesional_pre-dose | 455.34 | 66 |
GSM1296102 | U_non-lesional_pre-dose | 701.52 | 73 |
GSM1296122 | V_non-lesional_pre-dose | 557.06 | 69 |
GSM1296089 | W_non-lesional_pre-dose | 716.26 | 73 |
GSM1296083 | X_non-lesional_pre-dose | 1339.77 | 84 |
GSM1296116 | Y_non-lesional_pre-dose | 544.24 | 69 |
GSM1296085 | Z_non-lesional_pre-dose | 544.46 | 69 |